Advertisement

Banner BIO Deutschland European Business Development Conference 600x60px
All >

Deals > Germany

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Germany or involving German organisations.

Total search results: 6365 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 62 63 64  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
EcoMetals project–Germany (govt): grant, 201404– funding €4,2m from BMBF for 7 German project partners 2014-04-01
EcoMetals project–Helmholtz: industrial biotechnology, 201404– collab HZDR is lead scientific project partner in EcoMetals research programme 2014-04-01
Convergence Pharmaceuticals–Evotec: drug discovery services, 201403– collab €na pain drug r+d with Panion Ltd 2014-03-31
Univ Oulu–Bruker Corp: mass spectrometer, 201403 supply existent UltrafleXtreme MALDI Tof/Tof listed on web site of MS Core Facility 2014-03-30
Dichrom–Fortis Technologies: HPLC columns, 201403 distribution existent in Germany by Dichrom 2014-03-29
Genmab–MAB Discovery: drug discovery services, 201403– collab €na generation of antibodies for multiple Genmab targets 2014-03-27
MAB Discovery–MC Services: public relations, 201403 service existent for MAB Discovery GmbH 2014-03-27
Bionamics–Evotec: investment, 201403 acquisition €na 100% against cash + future milestone payments 2014-03-24
Evotec–Reach Separations: chromatography, 201403– collab with Reach becoming technology partner providing small molecule chromatography 2014-03-19
Seltenerden Storkwitz–BRAIN: industrial biotechnology, 201403– collab expansion strategic partnership biotech extraction of rare earth metals 2014-03-19
Activaero–Vectura: investment, 201403 acquisition €130m with €45m cash upfront + €35m in Aug 2015 + €50m in shares 2014-03-13
Inotrem–MC Services: public relations, 201403 service existent for Inotrem SA 2014-03-13
Chemie.DE–Köhl et Feling: public relations, 201403 service existent for Chemie.DE Information Service GmbH 2014-03-11
Exosome Diagnostics–Qiagen: investment, 201403 financing round Series B totalling $27m co-led by Qiagen + Arcus Ventures 2014-03-11
Glycotope–Eckert Wagniskapital: investment, 201403 financing round totalling €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
Glycotope–SEVERAL: investment, 201403 financing round €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
Glycotope–Strüngmann Group: investment, 201403 financing round totalling €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
Merus–Minapharm: GlymaxX technology, 201403– non-excl option + license agreem €na for use for bispecific cancer antibody from ProBioGen AG 2014-03-04
BRAIN–Germany (govt): grant, 201403– BMBF funding for collab BRAIN + Selterden Storkwitz to develop bio-mining pilot plant for rare earth metals 2014-03-01
Gerstel–Spark Holland: dried blood spot technology, 201402– supply OEM incl FTD technology + DBS Autosampler for automated DBS systems of Gerstel 2014-02-28
microDimensions–High-Tech Gründerfonds: investment, 201402 seed financing round with HTGF + Bayern Kapital + business angel Adriaan Hart de Ruijter 2014-02-27
microDimensions–SEVERAL: investment, 201402 seed financing round with HTGF + Bayern Kapital + business angel Adriaan Hart de Ruijter 2014-02-27
BRAIN–BASF: food ingredients, 201402 acquisition of anti-bitter patents + utility patents from BASF by BRAIN 2014-02-25
Sysmex–Roche: PCR technology, 201402– license ww non-excl for emPCR patent portfolio to Sysmex Inostics GmbH 2014-02-21
Proteros–MC Services: public relations, 201402 service existent for Proteros Biostructures GmbH 2014-02-20
Horizon Discovery–Sirion Biotech: genomic technology, 201402– supply to + distribution of RANiONE based services + reagents by Horizon 2014-02-17
4SC–Yorkville Group: credit, 201402– up to nominally €15m convertible notes to be purchased until 12/16 by YA Global Master SPV Ltd 2014-02-12
Coramaze Technologies–High-Tech Gründerfonds: investment, 201402 seed funding round totalling €1m co-led by HTGF + Seed Capital Dortmund 2014-02-12
Coramaze Technologies–SEVERAL: investment, 201402 seed funding round €1m co-led by HTGF + Seed Capital Dortmund 2014-02-12
Insilico Biotechnology–Pharmacelsus: drug development services, 201402– collab offering joint services for preclinical characterisation of APIs 2014-02-10
Werum–Körber: investment, 201402– acquisition of newly formed Werum IT Solutions AG by Körber Medipak 2014-02-10
Mologen–SEVERAL: investment, 201402 capital increase €15.7m gross proceeds 1,541,244 shares €10.2/share 2014-02-05
Bayer–Helmholtz: cancer research, 201402– collab strategic alliance 5y with DKFZ planned combined investment of up to €30m 2014-02-04
General Electric–Definiens: image analysis s/w, 201402– supply automated solutions to Clariant Diagnostic Services for clinical breast cancer testing 2014-02-03
LABiTec–HUMAN Diagnostics Worldwide: investment, 201401 acquisition €na of LAbor BioMedical Technologies GmbH 2014-01-30
Danaher–Univ Münster: mass spectrometry, 201401 collab developm LC/MS/MS method for halal food testing of meat with Institute for Food Chemistry 2014-01-28
Univ Münster–Danaher: mass spectrometer, 201401 supply existent use of AB Sciex QTRAP 5500 system with MRM by Institute for Food Chemistry 2014-01-28
Univ Münster–Danaher: mass spectrometer, 201401 supply existent use of AB Sciex TripleTOF 5600 system by Institute for Food Chemistry 2014-01-28
Trianta Immunotherapies–Medigene: investment, 201401 acquisition 100% for 1m shares worth €4m plus €5.875m milestones in shares or cash 2014-01-27
Axel Semrau–Bruker Corp: GC/MS solutions, 201401– collab configuration + sale of automated GC/MS solutions by Semrau using SCION TQ GC/MS systems 2014-01-21
Qiagen–Trinean: UV/VIS spectrophotometer, 201401– OEM manufacture + supply ww of QIAxpert system by Trinean 2014-01-18
Boehringer–Argen-X: SIMPLE antibody discovery platform, 201401– collab €na pilot research agreement 2014-01-13
Hopp Group–GATC Biotech: DNA sequencing, 201401– supply protocols + support + training + LIMS to Molecular Health Inc 2014-01-10
Probi–Symrise: investment, 201401– mandatory offering SEK40.1/share for all remaining shares of Probi AB after increase of Symrise holdings to 30.03% 2014-01-10
Aravis–College Group: public relations, 201401 service existent by College Hill Life Sciences 2014-01-09
Isarna Therapeutics–Santaris Pharma: LNA technology, 201401– license for use to discovery + develop + market TGF beta targeting immunotherapies 2014-01-08
Boehringer–Crystal Bioscience: therapeutic antibodies, 201401– collab discovery + developm for multiple targets 2014-01-07
Isarna Therapeutics–MIG Fonds: investment, 201401 financing round €13m from AT NewTec + MIG-managed funds 2014-01-07
Isarna Therapeutics–SEVERAL: investment, 201401 financing round €13m from AT NewTec + MIG-managed funds 2014-01-07
Isarna Therapeutics–Strüngmann Group: investment, 201401 financing round €13m from AT NewTec + MIG-managed funds 2014-01-07
AstraZeneca–Probiodrug: CDK9 inhibitors, 201401 acquistion €na of CDK9 inhibitor program by AstraZeneca 2014-01-03
Dinkelberg Analytics–Altmann Analytik: investment, 201401 acquisition 2014-01-01
Helmholtz–NN: mass spectrometer, 2014 supply PLANNED installation of SIMS at UFZ in Leipzig 2014-01-01
Laboratorios LETI–Curetis: Unyvero system, 201401– distribution excl in Spain + Portugal by Laboratorios LETI 2014-01-01
Optronik–Carl Zeiss: investment, 201312 acquisition 100% of former excl Turkish distribution partner by Carl Zeiss Meditec 2013-12-31
Boehringer–Circuit Therapeutics: drug target discovery, 201312– collab research €na 3y in field of psychiatric disorders 2013-12-18
Merck (DE)–CNIO: ATR kinase inhibitor, 201312– license excl rights to develop + commercialise ATR kinase inhibitors to Merck Serono 2013-12-18
Structural Genomics Consortium–Bayer: epigenetics, 201312– collab Bayer HealthCare joins SGC as new member 2013-12-18
Emergent BioSolutions–Minapharm: AGE1.CR cell line, 201312– license expansion €na broad non-excl commercial multi-product from ProBioGen 2013-12-17
Automation Partnership–Sartorius: investment, 201310–201312 acquisition €33m in cash of TAP Biosystems Group plc by Sartorius Stedim Biotech GmbH 2013-12-16
Strüngmann Group–Formycon: biosimilar, 201312– license ww excl to first biosimilar in Formycon’s pipeline to Santo Holding GmbH 2013-12-12
Bayer–Druggability Technologies: drug delivery technology, 201312– collab multi-year to deploy Super-API platform to Bayer HealthCare molecules 2013-12-05
FN Semillas–Bayer: investment, 201312 acquisition €na by Bayer CropScience 2013-12-05
Sonic Healthcare–Ariosa Diagnostics: Harmony Prenatal Test, 201312– supply Sonic Healthcare will offer test via Bioscientia in Germany 2013-12-05
Euroimmun–Mecklenburg-Vorpommern (govt): grant, 201312– grant €3.15m to support total Euroimmun €14m investment to expand Dassow facility 2013-12-04
Pfizer–Protagen: biomarker discovery services, 201312– collab use SeroTag process to identify markers for autoimmune drug developm 2013-12-03
Paion–Capital Ventures International: investment, 201312–201402 private placement €6.17 acquisition 2.55m new shares in 2 tranches by CVI 2013-12-01
TocopheRx–Merck (DE): investment, 201312 seed financing $3.2m from MS Ventures for spin-off from Merck Serono 2013-12-01
Algeta–Bayer: investment, 201311– acquisition proposal by Bayer NOK362/share valuing Algeta equity at €2.1b 2013-11-26
R-Pharm–Paion: remimazolam, 201310– license excl €1m upfront + €3m milestones + royalties for developm + manuf + marketing in Russia + CIS 2013-11-26
R-Pharm–Paion: remimazolam, 201311– license €1m upfront + €3m milestones + royalties for developm + marketing in Turkey to TR-Pharm 2013-11-26
Boehringer–Galapagos: drug discovery, 201311– supply integrated drug discovery services by BioFocus to undisclosed Boehringer target 2013-11-20
Definiens–Affect: public relations, 201311 service existent by Affect Inc 2013-11-20
Global Bioenergies–Germany (govt): grant, 201311– BMBF grant €5.7m for Global Bioenergies GmbH within BioEconomy programme 2013-11-20
Merck (DE)–Biopharm: therapeutic protein, 201311– collab €na r+d biopharmaceutical for osteoarthritis with Merck Serono 2013-11-20
Metamark Genetics–Definiens: image analysis s/w, 201311– collab + supply multi-year agreem to use Cognition Network Technology with ProMark test 2013-11-20
CI3 Cluster–AbbVie: personalised immunotherapy, 201311 collab existent AbbVie Deutschland GmbH & Co KG is cluster partner 2013-11-19
CI3 Cluster–Bayer: personalised immunotherapy, 201311 collab existent Bayer Vital GmbH is cluster partner 2013-11-19
CI3 Cluster–Biopharm: personalised immunotherapy, 201311 collab existent PW Technologies GmbH is cluster partner 2013-11-19
CI3 Cluster–Dr Falk Pharma: personalised immunotherapy, 201311 collab existent Dr Falk Pharma GmbH is cluster partner 2013-11-19
CI3 Cluster–GenXPro: personalised immunotherapy, 201311 collab existent GenXPro GmbH is cluster partner 2013-11-19
CI3 Cluster–Infraserv Höchst: personalised immunotherapy, 201311 collab existent Infraserv GmbH & Co Hoechst KG is cluster partner 2013-11-19
CI3 Cluster–itechpartners: personalised immunotherapy, 201311 collab existent itechpartners – Dr Rainer Wessel is cluster partner 2013-11-19
CI3 Cluster–Medatixx: personalised immunotherapy, 201311 collab existent Medatixx GmbH & Co KG is cluster partner 2013-11-19
CI3 Cluster–Medesso: personalised immunotherapy, 201311 collab existent Medesso GmbH is cluster partner 2013-11-19
CI3 Cluster–Molekularpathologie Trier: personalised immunotherapy, 201311 collab existent ProteoPath GbR is cluster partner 2013-11-19
CI3 Cluster–thinXXS Microtechnology: personalised immunotherapy, 201311 collab existent thinXXS Microtechnology AG is cluster partner 2013-11-19
Scopis–High-Tech Gründerfonds: investment, 201311 financing round Series A incl returning investor HTGF 2013-11-19
Scopis–SEVERAL: investment, 201311 financing round Series A from HTGF + VC Fonds Technologie Berlin + Falk Strascheg + Fraunhofer 2013-11-19
Strüngmann Group–SEVERAL: investment, 201311 Ganymed financing round Series E €45m from existing investors ATS + MIG Fond + FCPB Gany GmbH 2013-11-18
Merck (DE)–BeiGene: cancer drug, 201311– license ww + collab co-developm + commercialisation of PARP inhibitor BeiGene-290 by Merck Serono 2013-11-13
R-Biopharm–Candor Bioscience: immunoassays, 201311– strategic alliance in the area of companion diagnostics 2013-11-13
Roche–Immatics: cancer immunotherapy, 201311– strategic r+d collab €17m upfront + research funding + >€1b milestones to develop cancer vaccines 2013-11-13
Coral BioNet–Wacker: investment, 201311– acquisition 100% of Scil Proteins Production GmbH by Wacker Biotech GmbH from BioNet Ventures GmbH 2013-11-12
MeVis–PERSON: investment, 201311 shareholding of voting rights of Carl JG Evertsz has fallen to 14.995% 2013-11-11
JnJ–Evotec: drug discovery services, 201311– collab drug target discovery for Alzheimer drugs with JnJ Innovation Centre California 2013-11-08
Hookipa Biotech–Boehringer: investment, 201311 financing round Series B totalling €20m incl new + co-investor BIVF 2013-11-04
Merck (DE)–Kadimastem: drug discovery services, 201311– collab MOU drug screening + discovery for neurodegenerative disesases Merck Serono 2013-11-04
Strüngmann Group–4SC: drug discovery services, 201311– collab discovery + optimis small molecule anti-infectives by 4SC Discovery+Crelux for AiCuris 2013-11-04
Thermo Fisher–Univ Utrecht: mass spectrometry, 201311– collab developm applications + appointm of A Makarov as Professor 2013-11-04
next pagenext page 1 2 3 4 ... 62 63 64  next pagenext page



Advertisement

Banner BIO Deutschland European Business Development Conference 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Banner SwedenBIO Nordic Life Science Days 2015 Stockholm 600x60px

» top

Advertisements

Banner BIO Deutschland Deutsche Biotechnologietage 2015 Köln 120x240px Banner BIO Deutschland European Business Development Conference 120x240px Banner SwedenBIO Nordic Life Science Days 2015 Stockholm 600x60px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px